Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF AUGUST 18, 2013 FBO #4285
MODIFICATION

A -- Merck PedvaxHIB & Convax Vaccines

Notice Date
8/16/2013
 
Notice Type
Modification/Amendment
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
200-2013-54509
 
Archive Date
9/15/2013
 
Point of Contact
Michael A. Harwell, Phone: 7704883224
 
E-Mail Address
wyu4@cdc.gov
(wyu4@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
The Centers for Disease Control and Prevention, NCIRD/ISD, 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract to Merck Sharp & Dohme Corp. 1 Merck Drive Whithouse Station, NJ 08889-3400 to increase the ceiling on contract 200-2013-54509 in order to add PedvaxHIB and Comvax vaccines. NAICS Code: 325412 Period of Performance: 04/01/2013 to 03/31/2014 Contract Award Dollar Amount: $18,284,160 Contract Line Item Number: 0005 Award Date: 09/13/13 The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). It is critical to ensure that sufficient doses of PRP-OMP Hib-containing vaccines, which are only produced by one licensed manufacturer in the US and which are preferred for use in high risk children, including American Indian/Alaska Native (AI/AN) children, are available to fully protect children against invasive Hib disease. Not adding additional doses of these vaccines on Merck's contract will adversely impact CDC's ability to adequately protect pediatric patients, particularly high risk children such as American Indian/Alaska Native (AI/AN) children, against invasive Hib disease. Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2013-54509, Centers for Disease Control, Procurement and Grants Office, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov. This is a posting of a sole source award to Merck Sharp & Dohme Corp. and is not a request for competition.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/200-2013-54509/listing.html)
 
Place of Performance
Address: 1600 Clifton Rd. NE, Mailstop A19, Atlanta, GA, 30333, United States
Zip Code: 30333
 
Record
SN03152254-W 20130818/130816234935-e45bbcd22323ffe2d81b3e79bcbab359 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.